Chronic Plaque Psoriasis Market is segmented By Drug Class (Biologics, Small Molecule Drugs), By Route of Administration (Injectable, Oral, Topical), By Geography (North ....
Market Size in USD
CAGR6.5%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 6.5% |
Market Concentration | High |
Major Players | Novartis AG, Eli Lilly and Company, AbbVie Inc., Johnson & Johnson (Janssen Biotech), Amgen Inc. |
The chronic plaque psoriasis market is estimated to be valued at USD 22.9 Bn in 2024 and is expected to reach USD 35.6 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031. The rising prevalence of autoimmune and inflammatory diseases is expected to boost the number of new patients entering the market.